Merck remains confident ahead of Keytruda’s loss of exclusivity, projecting growth through new drug developments and expanded indications, signaling resilience amid increasing competition.
Browsing: drug exclusivity
Merck remains confident ahead of Keytruda’s loss of exclusivity, projecting growth through new drug developments and expanded indications, signaling resilience amid increasing competition.